/_media/adv/web/images/2010/20100131_SurgicalNotes_TB-378x82.gif

Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
/_media/adv/web/images/2010/20100126_ImageFirst_LB-154x100.gif
Outpatient Surgery E-Weekly

Safety Violations Close Florida Endo Center

The Florida Agency for Health Care Administration has prohibited the Fort Myers Endoscopy Center from treating patients after 19 regulatory violatio...

Ergonomic Complaints Common Among Laparoscopic Surgeons

Laparoscopic surgeons often stand in awkward positions as they maneuver their instruments through fixed ports for long stretches, making them prime ...

Nevada Hepatitis Lawyers Cite Drug Maker

Were a drug maker's packaging and instructions partially to blame for the hepatitis C outbreak that emerged from Nevada endoscopy centers between 20...

Home > News > November, 2009
Propofol Shortage Update: FDA Approves Importation From Europe
Manufacturer says you can begin ordering imported product immediately to deal with shortage.

The Food and Drug Administration has authorized the importation of propofol 1% injection from the European Union to deal with an ongoing shortage of the drug in the United States.

APP, manufacturer of Diprivan (propofol 1%), is working with the FDA to make Fresenius Propoven 1% available to U.S. providers. The drug "is manufactured in FDA inspected facilities by APP's parent company, Fresenius Kabi AG," and "contains the same active ingredient, propofol, in the same concentration as" Diprivan, APP explains in a letter being distributed with the imported product. Although the European product is "a clinically acceptable substitute to other currently marketed generic propofol products in the U.S.," there are important formulation and labeling differences between it and the U.S. version. The FDA encourages practitioners to review those differences, which are outlined in APP's letter.

If your facility has been hit by the propofol shortage, here are some other do's and don'ts experts say you should follow:

  • Do get listed early with your supplier for product delivery upon its availability, says pharmacy consultant Sheldon Sones, RPh, FASCP.

  • Do order the branded product Diprivan if it's available or consider ordering imported propofol; both are distributed by APP. The company says you can order the imported product either through your wholesaler or directly from APP by calling (888) 386-1300.

  • Don't hoard propofol supplies.

  • Don't try to stretch single-use vials of propofol across multiple cases. In a conference call early last month, FDA officials stressed that all propofol vials are intended for single use and that splitting doses poses an infection risk.

  • Do reserve some sulfite-free propofol for use in the 1% of the population that is truly allergic, says Mr. Sones, noting that the shortage hit sulfite-free supplies particularly hard.

  • Do keep in close contact with your supply representative and check the FDA's Web site for updates. If you have trouble obtaining adequate supplies, e-mail the FDA's Drug Shortage Group for assistance.

    Irene Tsikitas

  • Categories: Anesthesia, Product Reports, News
    Already have an account? Please sign in:
    Email Address:
    Password:
    PRODUCT & SERVICE RESOURCES
    Product & Service Showcase
    A showcase of products and services geared to make your facility better.
    Professional Services Platinum Pages
    A guide of people and companies to help make your facility better.
    Other Articles That May Interest You
    FDA: Congressional Pressure Influenced Approval of Knee Repair Device
    Report criticizes "unprecedented" exertion of interest by 4 lawmakers on behalf of ReGen.
    Promoting Hand Hygiene With Hip-Hop
    Boston hospital gets creative to boost handwashing compliance.
    N.J. Proposal Would Require ASCs to Report Infection Rates
    If passed, the health department would track and report ASC infection rates online.
    Comment on this Article
    Please login to leave a comment on this article.
    Recent Comments
    Please login to read comments on this article.